LAVENDER
Lavandula angustifoliaLavender is widely recognized for its potent anxiolytic and sedative properties, offering significant support for sleep quality, stress reduction, and mood stabilization.
Anxiolytic Effects and Sleep Architecture
Key Citations
Schuwald, A.M., Noldner, M., Nieber, K., et al. Lavender oil-potent anxiolytic properties via modulating voltage dependent calcium channels. PLoS One, 8(4), e59998 (2013)
López, V., Nielsen, B., Solas, M., et al. Exploring Pharmacological Mechanisms of Lavender (Lavandula angustifolia) Essential Oil on Central Nervous System Targets. Front. Pharmacol., 8, 280 (2017) Kasper, S., Gastpar, M., Müller, W.E., et al. Silexan, an orally administered Lavandula oil preparation, is effective in the treatment of 'subsyndromal' anxiety disorder: a randomized, double-blind, placebo controlled trial. Int. Clin. Psychopharmacol., 25(5), 277-287 (2010) Woelk, H., Schläfke, S. A multi-center, double-blind, randomised study of the Lavender oil preparation Silexan in comparison to Lorazepam for generalized anxiety. Phytomedicine, 17(2), 94-99 (2010) Goel, N., Kim, H., Lao, R.P. An olfactory stimulus modifies nighttime sleep in young men and women. Chronobiol. Int., 22(5), 889-904 (2005) Hancianu, M., Cioanca, O., Mihasan, M., et al. Neuroprotective effects of inhaled lavender oil on scopolamine-induced dementia via anti-oxidative activities in rats. Phytomedicine, 20(5), 446-452 (2013) Wang, D., Yuan, X., Liu, T., et al. Neuroprotective Activity of Lavender Oil on Transient Focal Cerebral Ischemia in Mice. Molecules, 17(8), 9803-9817 (2012) Kasper, S., Volz, H.P., Dienel, A., et al. Efficacy of Silexan in mixed anxiety-depression—A randomized, placebo-controlled trial. Eur. Neuropsychopharmacol., 26(2), 331-340 (2016) Sayorwan, W., Siripornpanich, V., Piriyapunyaporn, T., et al. The effects of lavender oil inhalation on emotional states, autonomic nervous system, and brain electrical activity. J. Med. Assoc. Thai., 95(4), 598-606 (2012) Cavanagh, H.M., Wilkinson, J.M. Biological activities of lavender essential oil. Phytother. Res., 16(4), 301-308 (2002) European Medicines Agency (EMA). Assessment report on Lavandula angustifolia Mill., aetheroleum. EMA/HMPC/143183/2010 (2012) Uehleke, B., Schaper, S., Dienel, A., et al. Phase II trial on the effects of Silexan in patients with neurasthenia, post-traumatic stress disorder or somatization disorder. Phytomedicine, 19(8-9), 665-671 (2012) Henley, D.V., Lipson, N., Korach, K.S., et al. Prepubertal gynecomastia linked to lavender and tea tree oils. N. Engl. J. Med., 356(5), 479-485 (2007)